Navigation Links
FDA Commissioner Margaret Hamburg, Bestselling Author Jim Collins to Keynote RAPS Annual Conference in Philadelphia
Date:8/28/2009

Conference to Examine Latest in Healthcare Product Regulation, Trends, Technology

ROCKVILLE, Md., Aug. 28 /PRNewswire-USNewswire/ -- Professionals concerned with developing and bringing safe and effective drugs, medical devices, biotechnology and other healthcare products to the worldwide market will convene in Philadelphia next month for the Regulatory Affairs Professionals Society's (RAPS) 2009 Annual Conference & Exhibition. Attendees will come from around the world for what is the largest annual event of its kind exclusively for regulatory professionals in the healthcare product sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO )

New US Food and Drug Administration (FDA) Commissioner Margaret Hamburg, MD, who has gained attention since taking office for her public statements about refocusing FDA on its public health mission, will address attendees as this year's closing keynote speaker. The 2009 RAPS Annual Conference & Exhibition, the theme of which is "Succeed in the New Regulatory Landscape," will take place at Philadelphia's Pennsylvania Convention Center, 13-16 September. Bestselling business author Jim Collins of Good to Great fame will open the conference's first official day of sessions with a keynote address on Monday, 14 September. For more information and a complete listing of conference sessions and events, visit www.raps.org/ac2009. Follow conference updates on Twitter at @RAPSAnnualConf.

"Regulatory professionals play a vital role in ensuring access to safe and effective medicines, medical devices and myriad other healthcare products by the patients and healthcare professionals who need them every day," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "It may not be thoroughly understood by the typical consumer, but these dedicated professionals are involved at every stage of healthcare product development and marketing. This conference is the premier event for regulatory professionals to gather, learn, network and hear from high-profile speakers like Dr. Hamburg and Jim Collins."

In addition to the keynote speakers, the conference will feature more than 25 additional senior FDA officials presenting at various sessions and briefings, as well as representatives from Japan's Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA), the Drugs Controller General of India (DCGI) and the Dutch Healthcare Inspectorate as well as many other healthcare and regulatory experts from around the world.

Among the topics to be examined at the conference are regulation of biosimilars; considerations for clinical trials of stem cell products; regulations governing counter-bioterrorism agents; health technology assessment and its relationship to comparative effectiveness research; global clinical trials; international regulatory considerations for drugs, devices, biotechnology and combination products; regulatory challenges in emerging markets; advertising and promotion; postmarket surveillance and more. Attendees also will receive briefings from representatives of FDA's Center for Devices and Radiological Health (CDRH) and Center for Drug Evaluation and Research (CDER), the European Medicines Agency (EMEA) and Health Canada.

Members of the working media wishing to cover all or part of the 2009 RAPS Annual Conference & Exhibition should contact RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or +1 301 770 2920, ext. 245. On-site registration also will be available and members of the media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Governor Rendell Directs Insurance Commissioner to Delay Mcare Abatement Collection
3. Providing Affordable Health Care Coverage Cited as a Top Priority, Commissioner Says
4. Council on Education in Management Announces Insurance Commissioner Steve Poizner Will Present Keynote Address at the 6th Annual California Workers' Comp Forum
5. Council on Education in Management Announces New Commissioner Rod Bordelon will Present a Keynote Address at the 5th Annual Texas Workers' Comp Forum
6. Insurance Commissioner Announces Retirement of George Hoover
7. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
10. Pennsylvania Insurance Commissioner Praises Federal Reauthorization of Childrens Health Care
11. AstraZeneca Applauds Appointment of New FDA Commissioner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... York, N.Y. (PRWEB) , ... May 23, 2017 , ... ... “A Public Health Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls ... Rory Staunton Foundation for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on ...
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, an Indianapolis-based digital healthcare ... on its secure clinical communication platform. The platform allows clinicians to easily escalate ... type and urgency of a situation. , “We know from our daily ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... receive treatment using the SPEED System™ Orthodontics, with or without a referral, from ... in El Segundo, CA, who is skilled in providing patients with the ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments ... Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer ... or more sedation methods may be recommended based on the severity of the anxiety ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: